Cartesian Therapeutics, Inc.
DE ˙ DB
5,30 € ↑0,32 (6,43%)
2026-06-05
DEL PRIS
SecurityDE:1S70 / Cartesian Therapeutics, Inc.
InstitutionBnp Paribas Arbitrage, Sa
Latest Disclosed Ownership9,950 shares
Latest Disclosed Value $ 61,192
Bnp Paribas Arbitrage, Sa reports 312.18% increase in ownership of 1S70 / Cartesian Therapeutics, Inc.

On May 12, 2026 - Bnp Paribas Arbitrage, Sa filed a 13F-HR form disclosing ownership of 9,950 shares of Cartesian Therapeutics, Inc. (DE:1S70) valued at $51,242 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 2,414 shares of Cartesian Therapeutics, Inc.. This represents a change in shares of 312.18% during the quarter. The current value of the position is $52,735 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F Cartesian Therapeutics Equity 816212302 9,950 7,536 312.18 61 258.82 0.0000
2026-02-10 2025-12-31 13F Cartesian Therapeutics Equity 816212302 2,414 174 7.77 17 -22.73 0.0000
2025-11-13 2025-09-30 13F Cartesian Therapeutics Equity 816212302 2,240 862 62.55 23 57.14 0.0000
2025-08-14 2025-06-30 13F Cartesian Therapeutics Equity 816212302 1,378 360 35.36 14 7.69 0.0000
2025-05-14 2025-03-31 13F Cartesian Therapeutics Equity 816212302 1,018 -627 -38.12 13 -55.17 0.0000
2025-02-14 2024-12-31 13F Cartesian Therapeutics Equity 816212302 1,645 -6 -0.36 29 11.54 0.0000
2024-11-13 2024-09-30 13F Cartesian Therapeutics Equity 816212302 1,651 909 122.51 27 30.00 0.0000
2024-08-13 2024-06-30 13F Cartesian Therapeutics Equity 816212302 742 742 20 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.